Dialysate Concentrates Used in Hemodialysis Safety Communication
Dialysate Concentrates Used in Hemodialysis: Safety Communication – Alkali Dosing Errors AUDIENCE: Nephrology, Nursing ISSUE: FDA is notifying health care providers to consider the presence and...
View ArticleCefepime Label Change drug risks
Cefepime:Label Change- Risk of Seizure in Patients Not Receiving Dosage Adjustments for Kidney Impairment Audience: Health Professional,Infectious Disease, Nephrology Issue: There have been cases of...
View ArticleSamsca tolvaptan Drug Warning
Samsca (tolvaptan): Drug Warning – Potential Risk of Liver Injury AUDIENCE: Gastroenterology, Nephrology, Pharmacy ISSUE: Otsuka and FDA notified healthcare professionals of significant liver injury...
View ArticleHydroxyethyl Starch Solutions FDA Safety Communication
Hydroxyethyl Starch Solutions: FDA Safety Communication – Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding AUDIENCE: Critical Care Medicine, Nephrology, Patient,...
View Article
More Pages to Explore .....